Literature DB >> 8973237

Human guinea pigs and the ethics of experimentation: the BMJ's correspondent at the Nuremberg medical trial.

P Weindling1.   

Abstract

Though the Nuremberg medical trial was a United States military tribunal, British forensic pathologists supplied extensive evidence for the trial. The BMJ had a correspondent at the trial, and he endorsed a utilitarian legitimation of clinical experiments, justifying the medical research carried out under Nazism as of long term scientific benefit despite the human costs. The British supported an international medical commission to evaluate the ethics and scientific quality of German research. Medical opinions differed over whether German medical atrocities should be given publicity or treated in confidence. The BMJ's correspondent warned against medical researchers being taken over by a totalitarian state, and these arguments were used to oppose the NHS and any state control over medical research.

Entities:  

Keywords:  BMJ (British Medical Journal); Biomedical and Behavioral Research; British Medical Association; Medical Research Council (Great Britain); National Health Service; Nuremberg Trials; Twentieth Century

Mesh:

Year:  1996        PMID: 8973237      PMCID: PMC2352949          DOI: 10.1136/bmj.313.7070.1467

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  1 in total

1.  Medical experiments on human beings in concentration camps in Nazi Germany.

Authors:  K MELLANBY
Journal:  Br Med J       Date:  1947-01-25
  1 in total
  3 in total

Review 1.  Should desperate volunteers be included in randomised controlled trials?

Authors:  P Allmark; S Mason
Journal:  J Med Ethics       Date:  2006-09       Impact factor: 2.903

2.  The Nuremberg doctors' trial: the 60th anniversary.

Authors:  François Lemaire
Journal:  Intensive Care Med       Date:  2006-11-17       Impact factor: 17.440

3.  Status of national research bioethics committees in the WHO African region.

Authors:  Joses M Kirigia; Charles Wambebe; Amido Baba-Moussa
Journal:  BMC Med Ethics       Date:  2005-10-20       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.